source
- Capricor’s Duchenne drug deramiocel receives negative FDA advisory vote on heart outcomeMindy Leffler, a parent of a young man with Duchenne muscular dystrophy, writes an opinion piece about Capricor’s phase 3 study of its drug deramiocel. She describes her son’s experience living ind…
- Experts warn protein restriction could harm older adults and GLP-1 patientsResearchers have recently suggested that limiting dietary protein might improve metabolic health and extend lifespan, a claim highlighted in a review paper in Cell Press Blue. Nutrition specialist…